Skip to content
HowShorted

Twist Bioscience Corp short interest in 2025

In 2025, Twist Bioscience Corp's disclosed short interest ran from 15.46% of shares outstanding on 15 Jan 2025 to 23.32% on 31 Dec 2025, a change of +7.86 percentage points. The year's high was 23.32% on 31 Dec 2025 and its low 14.48% on 31 Jan 2025, averaging 17.88% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.41 days on 15 Jan 2025. Full history: Twist Bioscience Corp.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Twist Bioscience Corp in 2025

2025 in figures

Start of year
15.46% (15 Jan 2025)
End of year
23.32% (31 Dec 2025)
Change
+7.86 pp
High
23.32% (31 Dec 2025)
Low
14.48% (31 Jan 2025)
Average
17.88%
Highest days to cover
13.41 (15 Jan 2025)
SEC filings marked
8

Every report in 2025

Twist Bioscience Corp short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202515.46%13.41
31 Jan 202514.48%11.45
14 Feb 202515.45%8.7510-Q filed, results (8-K)
28 Feb 202515.59%9.36
14 Mar 202514.80%6.15
31 Mar 202516.08%11.25
15 Apr 202516.31%5.94
30 Apr 202516.70%10.71
15 May 202517.72%7.8810-Q filed, results (8-K)
30 May 202517.83%9.38
13 Jun 202517.21%8.36
30 Jun 202518.41%10.66
15 Jul 202517.93%11.95
31 Jul 202517.29%11.50
15 Aug 202518.24%4.2010-Q filed, results (8-K)
29 Aug 202516.96%9.27
15 Sep 202521.23%7.89
30 Sep 202521.51%8.12
15 Oct 202517.99%5.37
31 Oct 202517.48%6.38
14 Nov 202517.82%5.89results (8-K)
28 Nov 202520.86%6.8110-K filed
15 Dec 202522.47%11.65
31 Dec 202523.32%13.04

See also: Twist Bioscience Corp's full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.